Sentinel Lymph Node Biopsy

A sentinel lymph node biopsy is a staging procedure used to identify and remove the first lymph node or nodes most likely to receive drainage from a primary tumor. It is commonly discussed in cancers such as breast cancer and melanoma when clinicians need to know whether microscopic spread to regional lymph nodes has occurred. ^[1][2][3]

The aim is to obtain staging information while avoiding the higher morbidity of removing many lymph nodes unnecessarily. In selected patients, this can reduce the risk of complications such as lymphedema, numbness, and shoulder dysfunction compared with more extensive nodal surgery. ^[1][2][4]

Why is a sentinel lymph node biopsy performed?

The main reason is nodal staging. A negative sentinel node can support the conclusion that there is no detectable regional nodal spread at that time, while a positive result may alter staging, prognosis, and the overall treatment plan. ^[1][2][3]

However, the exact role of the procedure depends on tumor type, tumor thickness or size, imaging, and the broader treatment strategy. Not every patient with breast cancer or melanoma needs sentinel node biopsy. ^[2][3][5]

How is the procedure performed?

Before or during surgery, a tracer such as a radioactive substance, blue dye, or both is used to map lymphatic drainage from the tumor area. The surgeon then identifies the node or nodes that first receive that drainage and removes them for pathologic examination. ^[1][2][4]

The procedure is usually performed together with surgery on the primary tumor, such as breast-conserving surgery, mastectomy, or wide local excision for melanoma. Pathology results then help determine whether additional treatment is needed. ^[1][2][3]

Advantages, limitations, and possible risks

A major advantage is less tissue disruption than full nodal dissection in selected cases. Even so, sentinel node biopsy is not risk-free. Bleeding, infection, seroma, dye-related reactions, temporary discomfort, and lymphedema can still occur, although the risk profile is generally lower than with more extensive node removal. ^[1][2][4]

Like any diagnostic procedure, it also has limits. A negative result does not mean a person can never develop recurrence, and a positive result does not automatically mean extensive nodal surgery will always be required. Management depends on the full clinical context. ^[2][3][5]

Recovery and when to contact a doctor

Most patients focus on wound care, activity guidance, and monitoring for swelling, redness, fever, drainage, or increasing pain. Depending on the surgical site, shoulder range of motion or arm swelling may also be monitored carefully. ^[1][2][4]

How can the pathology result affect treatment planning?

The pathology result may influence cancer stage, adjuvant therapy decisions, radiation planning, and the need for closer follow-up. Today, the next step after a positive sentinel node is often individualized rather than automatic, which is why patients should discuss the result in detail with their cancer team. ^[2][3][5]

Useful questions to ask before surgery

Patients often benefit from asking why the procedure is recommended, whether it will change treatment decisions, what the lymphedema risk is, what type of mapping will be used, and what would happen if the node is positive or cannot be identified. ^[1][2][3]